The Need for Classification Criteria of Immune Checkpoint Inhibitor-induced inflammatory Arthritis: A Scoping Review. Review uri icon

Overview

abstract

  • Immune checkpoint inhibitor-induced inflammatory arthritis (ICI-IA) is an immune-related adverse event that can occur as a result of receiving ICIs for cancer treatment. Thus far, ICI-IA has been described variably in the literature, in part due to varying presentations that evolve over time, as well as a lack of standardized definitions and classification. This scoping review aggregates various descriptions of ICI-IA, highlighting the most prominent attributes of ICI-IA from categories such as symptoms, signs, imaging, and laboratory findings as well as discussing potential mimic conditions.

publication date

  • March 12, 2024

Research

keywords

  • Arthritis
  • Immune Checkpoint Inhibitors

Identity

Scopus Document Identifier

  • 85187564991

Digital Object Identifier (DOI)

  • 10.1016/j.rdc.2024.02.006

PubMed ID

  • 38670730

Additional Document Info

volume

  • 50

issue

  • 2